NCT01328262

A Randomized Clinical Trial on Hemoglobin Dose and Patient Matching

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Haukeland University Hospital · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate whether the targeted hemoglobin increment (2 grams per decilitre) in the patient can be predicted from the hemoglobin dose/weight of the blood bag transfused. In the test group, the hemoglobin dose needed will be calculated, whereas in the control group, the prescribed number of red cell units will be transfused. Hypothesis: By matching the hemoglobin dose to the individual needs of the patient the investigators will reduce the total usage of red cell concentrates.

Detailed description

This is a randomized clinical study on hemoglobin dose and patient matching. The aim of the study is to evaluate whether the targeted hemoglobin increment (2 grams per decilitre) in the patient can be predicted from the hemoglobin dose/weight of the blood bag transfused. In the test group, the hemoglobin dose needed will be calculated, whereas in the control group, the prescribed number of red cell units will be transfused.

Conditions

• Anemia

Interventions

Type	Name	Description
OTHER	Calculated red blood cell transfusion	The subjects receive an amount of red blood cells that has been calculated from their body surface area.
OTHER	Standard red blood cell transfusion	The subjects in this group receive the prescribed number of red blood cell units.

Timeline

• Start date: 2010-11-01
• Primary completion: 2011-02-01
• Completion: 2011-02-01
• First posted: 2011-04-04
• Last updated: 2025-04-17
• Results posted: 2025-04-17

Locations

1 site across 1 country: Norway